MD — Pediatrix Medical Group Inc. stock price and chart

$28.08+2.86%

as of close, Oct 20, 2026

☾ AH $28.08 +2.86%

Pediatrix Medical Group Inc.Stock · HealthcareRussell 2000 · 0.07% of IWMUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEEE

20162019202120242026

10.020.030.040.050.060.070.0010.0M20.0M$28.08

2026-10-20

Price$28.08

MA20$25.54

MA50$22.31

Vol2.2M

What would $1,000 invested in MD be worth today? →

MD returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $28.08
YTD price return: +31.28%
YTD total return: +31.28%
Next earnings: Nov 2, 2026
Market cap: 2.3B2016-12 6.2B2026-10 2.3B-63.4% over the window
Enterprise value: 2.6B
Shares outstanding: 81.3M2016-06 93.6M2026-06 81.3M-13.2% over the window
52W low: $16.47
52W high: $28.29
From 52W high: -0.74%
From 52W low: +70.49%
52W range: 98%

Volume

Rel volume: 0.97×
30D volume: 728.6K
30D $ vol: 19.2M

Fundamentals

Sales (ttm): 2B2016-12 3.2B2026-06 2B-38.7% over the window
Sales/share: $24.012016-12 $33.942026-06 $24.01-29.3% over the window
EPS (ttm): $2.092016-06 $3.582026-06 $2.09-41.7% over the window
FCF (ttm): 228.6M2016-06 359.4M2026-06 228.6M-36.4% over the window
FCF/share: $2.812016-06 $3.842026-06 $2.81-26.7% over the window
Book value/share: $10.842016-06 $27.342026-06 $10.84-60.3% over the window
Net margin: 8.96%2016-12 10.2%2026-06 9.0%-12.2% over the window
ROE: 19.84%2016-06 13.0%2026-06 19.8%+52.1% over the window
ROA: 8.21%2016-06 7.0%2026-06 8.2%+17.3% over the window
Debt / equity: 0.45×2016-12 0.612026-06 0.45-25.7% over the window
Current ratio: 1.322016-06 1.652026-06 1.32-20.3% over the window

Growth (CAGR, ttm) · 10Y

Sales: +0.51%2025-06-30 → 2026-06-301.9B → 2B (+0.5% total)-0.75%2023-06-30 → 2026-06-302B → 2B (-2.2% total)+1.65%2021-06-30 → 2026-06-301.8B → 2B (+8.6% total)-5.03%2016-12-31 → 2026-06-303.2B → 2B (-38.7% total)
Net income: +59.08%2025-06-30 → 2026-06-30109.9M → 174.8M (+59.0% total)+19.32%2023-06-30 → 2026-06-30102.9M → 174.8M (+69.9% total)n/a-6.26%2016-06-30 → 2026-06-30333.8M → 174.8M (-47.6% total)
FCF: +0.72%2025-06-30 → 2026-06-30227M → 228.6M (+0.7% total)+18.03%2023-06-30 → 2026-06-30139M → 228.6M (+64.4% total)+18.21%2021-06-30 → 2026-06-3099M → 228.6M (+130.8% total)-4.42%2016-06-30 → 2026-06-30359.4M → 228.6M (-36.4% total)
Shares: -6.70%2025-06-30 → 2026-06-3087.1M → 81.3M (-6.7% total)-1.08%2023-06-30 → 2026-06-3083.9M → 81.3M (-3.2% total)-1.20%2021-06-30 → 2026-06-3086.3M → 81.3M (-5.9% total)-1.40%2016-06-30 → 2026-06-3093.6M → 81.3M (-13.2% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +60.98%2025-06-30 → 2026-06-30$1.30 → $2.09 (+60.9% total)+18.69%2023-06-30 → 2026-06-30$1.25 → $2.09 (+67.2% total)n/a-5.26%2016-06-30 → 2026-06-30$3.58 → $2.09 (-41.7% total)
Sales/share: +7.73%2025-06-30 → 2026-06-30$22.29 → $24.01 (+7.7% total)+0.33%2023-06-30 → 2026-06-30$23.77 → $24.01 (+1.0% total)+2.89%2021-06-30 → 2026-06-30$20.82 → $24.01 (+15.3% total)-3.58%2016-12-31 → 2026-06-30$33.94 → $24.01 (-29.3% total)
FCF/share: +7.95%2025-06-30 → 2026-06-30$2.61 → $2.81 (+7.9% total)+19.32%2023-06-30 → 2026-06-30$1.66 → $2.81 (+69.9% total)+19.65%2021-06-30 → 2026-06-30$1.15 → $2.81 (+145.2% total)-3.07%2016-06-30 → 2026-06-30$3.84 → $2.81 (-26.7% total)
Book value/share: +13.26%2025-06-30 → 2026-06-30$9.57 → $10.84 (+13.2% total)-1.15%2023-06-30 → 2026-06-30$11.23 → $10.84 (-3.4% total)+2.96%2021-06-30 → 2026-06-30$9.37 → $10.84 (+15.7% total)-8.83%2016-06-30 → 2026-06-30$27.34 → $10.84 (-60.3% total)
Price: +66.41%2025-10-20 → 2026-10-20$16.88 → $28.08 (+66.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+30.54%2023-10-20 → 2026-10-20$12.62 → $28.08 (+122.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.06%2021-10-20 → 2026-10-20$26.64 → $28.08 (+5.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-8.33%2016-10-19 → 2026-10-20$67.02 → $28.08 (-58.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +66.41%2025-10-20 → 2026-10-20$16.88 → $28.08 (+66.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+30.54%2023-10-20 → 2026-10-20$12.62 → $28.08 (+122.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.06%2021-10-20 → 2026-10-20$26.64 → $28.08 (+5.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-8.33%2016-10-19 → 2026-10-20$67.02 → $28.08 (-58.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 13.5×2016-12 18.382026-10 13.05-29.0% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 10.6×2016-12 10.762026-10 10.59-1.6% over the window
Fwd P/E: 11.2×
P/S (ttm)Market cap ÷ TTM revenue.: 1.2×2017-03 2.032026-10 1.17-42.3% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.6×2016-12 2.342026-10 2.59+10.7% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 10.0×2016-12 16.372026-10 9.98-39.0% over the window
EV/EBITDA (fy): 11.0×
EV/Sales (ttm): 1.3×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 10.02%2016-09 6.1%2026-06 11.1%+81.8% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 81.3M ÷ 87.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 6.70%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (6.70%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 6.70%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($146.1M) ÷ today's market cap ($2.3B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 6.41%2016-09 0.7%2026-06 7.1%+935.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $146.1M + TTM dividends $0) ÷ today's market cap ($2.3B). Same caveat as the cash buyback yield.: 6.41%2016-09 0.7%2026-06 7.1%+935.0% over the window

Vs own 10Y history

P/E: 46th
P/OI: 68th
P/S: 69th
P/B: 90th
P/FCF: 60th

Bar = where today’s multiple sits in MD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.86%

+5.52%

+8.29%

+9.22%

YTD

+31.28%

+66.35%

+5.41%

Financial statements

Open full MD financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

MD — Pediatrix Medical Group Inc. price, chart and key statistics